Next Article in Journal
Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients
Previous Article in Journal
Increased Extracellular Matrix Protein Production in Chronic Diabetic Complications: Implications of Non-Coding RNAs
ncrna-logo
Article Menu

Article Menu

Open AccessProject Report

Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129

1
Cardiovascular Research Unit, Luxembourg Institute of Health, L-1445 Strassen, Luxembourg
2
Department of Pharmacology and Pharmacotherapy, Semmelweis University, 1085 Budapest, Hungary
3
Department of Intelligent Systems, Jozef Stefan Institute, 1000e Ljubljana, Slovenia
4
Department of Medical Biology, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey
5
Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, UK
6
Institute for Heart Research, Centre of Experimental Medicine, Slovak Academy of Sciences, 84104 Bratislava, Slovakia
7
Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece
8
Integrated BioBank of Luxembourg, L-3550 Dudelange, Luxembourg
9
Faculty of Health Sciences, University of Malta, MSD 2080 Msida, Malta
10
Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia
11
Department Cardiovascular, Humanitas Research Hospital, 20089 Rozzano, Italy
12
Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, PB 4956 Nydalen, NO-0424 Oslo, Norway
13
Firalis, 68330 Huningue, France
14
Institute of Biomedical Research of Barcelona (IIBB)—Spanish National Research Council (CSIC), 08036 Barcelona, Spain
15
Mental Health Center Sct. Hans, 4000 Roskilde, Denmark
16
Instituto de Medicina Molecular, Faculty Medicine, University Lisboa, 1649-028 Lisboa, Portugal
17
Department of Life and Health Sciences, School of Sciences and Engineering, University of Nicosia, 2417 Nicosia, Cyprus
18
Department of Cardiology, Medical University of Vienna, 1090 Vienna, Austria
19
TAmiRNA, 1190 Vienna, Austria
20
Faculty of Engineering and Natural Sciences, International University of Sarajevo, 71210 Sarajevo, Bosnia and Herzegovina
21
Biogazelle, 9052 Zwijnaarde, Belgium
22
School for Cardiovascular Diseases, Faculty Health, Medicine and Life Sciences, Maastricht University, 6229ER Maastricht, The Netherlands
23
Department of Developmental Cardiology, Institute of Physiology of the Czech Academy of Sciences, 142 20 Prague, Czech Republic
24
Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU Norwegian University of Technology and Science, NO-7489 Trondheim, Norway
25
Department of Physiology, Institute for Biological Research “Siniša Stanković,” University of Belgrade, 11000 Belgrade, Serbia
26
Department of Biology, Faculty of Natural Sciences and Mathematics, University of Tuzla, 75000 Tuzla, Bosnia and Herzegovina
27
Department of Basic Sciences, University of Crete Medical School and Institute of Molecular Biology and Biotechnology (IMBB), Foundation for Research and Technology of Hellas, Heraklion 71003, Crete, Greece
28
Research Unit of Biomedicine, University of Oulu, 90014 Oulu, Finland
29
Department of Biomedicine and Clinic of Cardiology, University Hospital and University of Basel, 4031 Basel, Switzerland
30
Minerva Institute for Medical Research, 00290 Helsinki, Finland
31
The Cardinal Stefan Wyszynski Institute of Cardiology, 04-628 Warsaw, Poland
32
Center for Molecular Medicine, Karolinska Institute, 17176 Stockholm, Sweden
33
Molecular Cardiology Laboratory, IRCCS-Policlinico San Donato, 20097 San Donato Milanese, Milan, Italy
34
Department of Physiology, University of Valencia and INCLIVA Biomedical Research Institute INCLIVA, 46010 Valencia, Spain
35
Regenerative Medicine Institute REMEDI, National University of Ireland Galway (NUIG), H91 TK33 Galway, Ireland
36
Experimental Cardiology Unit, Division of Cardiology, Department of Cardiovascular Medicine, University of Lausanne Medical School, 1011 Lausanne, Switzerland
37
INSERM, Institut Pasteur de Lille, 59019 Lille Cedex, France
38
Babes-Bolyai University, 400084 Cluj-Napoca, Romania
39
University Hospital Centre Sisters of Charity, Institute for clinical medical research and education, 10 000 Zagreb, Croatia
40
Department of Cardiology, Centre for Heart Failure Research, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 ER Maastricht, The Netherlands
41
Institute for Drug Research, Faculty of Medicine, The Hebrew University, 91120 Jerusalem, Israel
42
Institute for Medical Informatics, Statistics and Epidemiology IMISE, Medical Faculty, University of Leipzig, 04107 Leipzig, Germany
43
Institute of Cellular Biology and Pathology “Nicolae Simionescu”, 050568 Bucharest, Romania
44
Westfälische Wilhelms-Universität Münster, Institute of Human Genetics, Department of Genetic Epidemiology, 48149 Münster, Germany
45
International Clinical Research Center, 656 91 Brno, Czech Republic
46
Dokuz Eylul University, Faculty of Medicine, Department of Cardiology, 35340 Izmir, Turkey
47
National Heart & Lung Institute, Faculty of Medicine, Imperial College London, London W12 0HH, UK
*
Author to whom correspondence should be addressed.
Non-Coding RNA 2019, 5(2), 31; https://doi.org/10.3390/ncrna5020031
Received: 7 March 2019 / Revised: 25 March 2019 / Accepted: 26 March 2019 / Published: 29 March 2019
Cardiovascular disease (CVD) remains the leading cause of death worldwide and, despite continuous advances, better diagnostic and prognostic tools, as well as therapy, are needed. The human transcriptome, which is the set of all RNA produced in a cell, is much more complex than previously thought and the lack of dialogue between researchers and industrials and consensus on guidelines to generate data make it harder to compare and reproduce results. This European Cooperation in Science and Technology (COST) Action aims to accelerate the understanding of transcriptomics in CVD and further the translation of experimental data into usable applications to improve personalized medicine in this field by creating an interdisciplinary network. It aims to provide opportunities for collaboration between stakeholders from complementary backgrounds, allowing the functions of different RNAs and their interactions to be more rapidly deciphered in the cardiovascular context for translation into the clinic, thus fostering personalized medicine and meeting a current public health challenge. Thus, this Action will advance studies on cardiovascular transcriptomics, generate innovative projects, and consolidate the leadership of European research groups in the field. COST (European Cooperation in Science and Technology) is a funding organization for research and innovation networks (www.cost.eu). View Full-Text
Keywords: cardiovascular disease; transcriptomics; best practices and guidelines; translational research; personalized medicine cardiovascular disease; transcriptomics; best practices and guidelines; translational research; personalized medicine
Show Figures

Figure 1

MDPI and ACS Style

Gomes, C.P.C.; Ágg, B.; Andova, A.; Arslan, S.; Baker, A.; Barteková, M.; Beis, D.; Betsou, F.; Bezzina Wettinger, S.; Bugarski, B.; Condorelli, G.; da Silva, G.J.J.; Danilin, S.; de Gonzalo-Calvo, D.; Buil, A.; Carmo-Fonseca, M.; Enguita, F.J.; Felekkis, K.; Ferdinandy, P.; Gyöngyösi, M.; Hackl, M.; Karaduzovic-Hadziabdic, K.; Hellemans, J.; Heymans, S.; Hlavackova, M.; Hoydal, M.A.; Jankovic, A.; Jusic, A.; Kardassis, D.; Kerkelä, R.; Kuster, G.M.; Lakkisto, P.; Leszek, P.; Lustrek, M.; Maegdefessel, L.; Martelli, F.; Novella, S.; O’Brien, T.; Papaneophytou, C.; Pedrazzini, T.; Pinet, F.; Popescu, O.; Potočnjak, I.; Robinson, E.; Sasson, S.; Scholz, M.; Simionescu, M.; Stoll, M.; Varga, Z.V.; Vinciguerra, M.; Xuereb, A.; Yilmaz, M.B.; Emanueli, C.; Devaux, Y. Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129. Non-Coding RNA 2019, 5, 31.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop